Vanicoside E

• Description :

  Vanicoside E is an antioxidant and antitumor agent. Vanicoside E inhibits L-Tyrosine (HY-N0473) and L-DOPA (HY-N0304) with IC50s of 45.23 μM and 189.96 μM, respectively[1][2].

• CAS Number :

  [208707-91-9]

• UNSPSC :

  12352005

• Target :

  Dopamine Receptor

• Type :

  Natural Products

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/vanicoside-e.html

• Solubility :

  10 mM in DMSO

• Smiles :

  OC(C=C1)=CC=C1/C=C/C(OC[C@@]2([C@H]([C@@H]([C@H](O2)COC(/C=C/C3=CC=C(C=C3)O)=O)O)OC(/C=C/C4=CC=C(C=C4)O)=O)O[C@@H]5[C@@H]([C@H]([C@@H]([C@H](O5)COC(/C=C/C6=CC(OC)=C(C=C6)O)=O)OC(C)=O)O)OC(C)=O)=O

• Molecular Formula :

  C53H52O22

• Molecular Weight :

  1040.97

• References & Citations :

  [1]Masum M N, et al. Isolation of phenylpropanoid sucrose esters from the roots of Persicaria orientalis and their potential as inhibitors of melanogenesis. Medicinal Chemistry Research, 2019, 28: 623-632.|[2]Panda P, et al. Phenylpropanoid sucrose esters: plant-derived natural products as potential leads for new therapeutics. Curr Med Chem. 2011;18 (21) :3234-51.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Natural Products

• Clinical Information :

  No Development Reported